Table 4.
Regression analysis of patient and CDI characteristics with utility decrement as the outcome variable
| Variable (reference) | Estimate | 95% LL | 95% UL | P-value |
|---|---|---|---|---|
| Gender (male) | −0.100 | −0.2668 | 0.0664 | 0.2347 |
| Age (≥65 years) | 0.240 | 0.0229 | 0.4579 | 0.0308 |
| Recurrence (No) | −0.042 | −0.279 | 0.194 | 0.7217 |
| Immunosuppression (No) | 0.0072 | − 0183 | 0.198 | 0.9398 |
| Charlson score (≥5) | −0.076 | −0.288 | 0.135 | 0.4730 |
| Zar score (< 3) | −0.374 | −0.609 | − 0.138 | 0.0023 |
| EQ-5D at baseline (< 0) | −0.210 | − 0.423 | 0.003 | 0.0535 |
LL lower limit, UL upper limit